American pharmaceutical prices

Printer-friendly version
Trump executive order may limit access to prescription drugs in Canada

Drug manufacturers may forgo sales in Canada to increase average reference prices.

Printer-friendly version

U.S. pharmaceutical innovation has been disproportionately funded by U.S. consumers of patented drugs.

Printer-friendly version

Canadians (and other non-Americans) benefit from research and development aimed primarily at the U.S. market.